RO 4-4602 AND LEVODOPA IN TREATMENT OF PARKINSONISM

被引：9

作者：

MILLER, EM ^{[1
]}

WIENER, L ^{[1
]}

机构：

[1] MAIMONIDES MED CTR,DEPT MED,4802 10TH AVE,BROOKLYN,NY 11219

来源：

NEUROLOGY | 1974年 / 24卷 / 05期

关键词：

D O I：

10.1212/WNL.24.5.482

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：482 / 486

页数：5

共 23 条

[1]

BARBEAU A, 1972, CAN MED ASSOC J, V106, P1169

[2]

BARBEAU A, 1971, CLIN PHARMACOL THER, V12, P353

[3]

Barbeau A, 1970, L DOPA PARKINSONISM

[4] EFFECT OF VARIOUS DECARBOXYLASE INHIBITORS ON CEREBRAL METABOLISM OF DIHYDROXYPHENYLALANINE [J].

BARTHOLINI, G ;

PLETSCHER, A .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1969, 21 (05) :323-+

[5] INCREASE OF CEREBRAL CATECHOLAMINES CAUSED BY 3,4-DIHYDROXYPHENYLALANINE AFTER INHIBITION OF PERIPHERAL DECARBOXYLASE [J].

BARTHOLINI, G ;

BURKARD, WP ;

PLETSCHER, A ;

BATES, HM .

NATURE, 1967, 215 (5103) :852-+

[6] MODERN TREATMENT OF PARKINSONISM [J].

BIRKMAYER, W ;

NEUMAYER, E .

ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04) :257-+

[7]

Birkmayer W, 1967, Arch Psychiatr Nervenkr (1970), V210, P29, DOI 10.1007/BF01217333

[8]

Birkmayer W, 1969, Wien Klin Wochenschr, V81, P677

[9] METHYLDOPAHYDRAZINE AS AN ADJUNCT TO L-DOPA THERAPY IN PARKINSONISM [J].

CHASE, TN ;

WATANABE, AM .

NEUROLOGY, 1972, 22 (04) :384-&

[10]

Cote L, 1970, Trans Am Neurol Assoc, V95, P73

← 1 2 3 →